Archive: 2026/06 - Page 2
Medical Society Guidelines on Generic Drugs: Official Positions and Provider Perspectives
Explore official medical society guidelines on generic drug use. Learn about FDA bioequivalence, NTI drug risks, and specialty positions from the AAN and AMA.
EU Generic Drug Mobility: How Cross-Border Pharmacy Services Work in 2026
Discover how EU cross-border pharmacy services enable seamless access to generic drugs. Learn about MyHealth@EU, ePrescriptions, and new 2026 regulations for travelers.
Patent Exclusivity vs Market Exclusivity: Key Differences Explained
Discover the key differences between patent exclusivity and market exclusivity in pharma. Learn how USPTO patents and FDA regulatory protections work together to control drug competition and pricing.
- 1
- 2